Core Viewpoint - Shenzhen Jieshun Technology Industrial Co., Ltd. has approved the cancellation of certain stock options due to the departure of five incentive targets, resulting in the cancellation of 192,500 stock options that have been granted but not exercised [1] Group 1 - The company held a meeting on August 25, 2025, to review and approve the cancellation of stock options [1] - The total number of initial incentive targets has been reduced from 200 to 195 [1] - The number of unexercised stock options has decreased from 9,319,800 to 9,127,300 [1] Group 2 - The reserved stock options for future incentive targets and the number of unexercised options remain unchanged [1] - The cancellation is in compliance with relevant regulations and has no substantial impact on the company [1]

Core Points - Weichuang Electric (688698.SH) announced the achievement of the initial grant conditions for the 2025 stock option incentive plan [1] - The company held its third board meeting on September 12, 2025, to review and approve the proposal for the initial grant of stock options to the incentive recipients [1] - A total of 2.57 million stock options will be granted at an exercise price of 59.18 yuan per option to 151 incentive recipients [1]

Group 1 - On September 5, 2025, Junshi Biosciences (688180) closed at 48.0 yuan, up 7.38%, with a turnover rate of 3.3% and a trading volume of 252,900 shares, amounting to a transaction value of 1.173 billion yuan [1] - On the same day, there was a net inflow of 12.36 million yuan from institutional investors, accounting for 1.05% of the total transaction value, while retail investors saw a net inflow of 13.08 million yuan, also representing 1.11% of the total [1][4] - A block trade occurred on September 5, with a transaction amount of 47.66 million yuan [2][4] Group 2 - Junshi Biosciences will hold its first extraordinary general meeting of shareholders on September 26, 2025, to review several proposals, including the election of Yang Jin as an independent non-executive director and the introduction of a stock option incentive plan for 2025 [3][4] - The company plans to issue 41 million H-shares, increasing its registered capital from 985,689,871 yuan to 1,026,689,871 yuan, and will abolish the supervisory board, transferring its duties to the audit committee of the board [2][4] - The company announced that its anti-IL-17A monoclonal antibody JS005 has achieved the primary endpoint in a Phase III clinical trial for moderate to severe plaque psoriasis, with plans to submit a marketing authorization application soon [4][7]

Core Points - The company has reviewed and approved the 2025 Stock Option Incentive Plan, confirming the eligibility of the incentive recipients [1][2] - A total of 1,227,000 stock options will be granted to 266 incentive recipients, with the grant date set for September 4, 2025 [2] Summary by Sections - **Eligibility of Incentive Recipients** - The incentive recipients do not fall under any disqualifying conditions as outlined in the relevant regulations [1] - The recipients meet the qualifications set forth in the Securities Law and the Stock Option Incentive Management Measures [2] - **Approval and Compliance** - The board's Compensation and Assessment Committee has deemed the procedures and content of the incentive plan to be legal and compliant, supporting the company's sustainable development [2] - There are no circumstances that would harm the interests of the company or its shareholders [2]

Core Points - The company has approved the 2025 Stock Option Incentive Plan, which includes a list of eligible participants for stock options [1][2] - The Supervisory Board has confirmed that the selected participants meet the criteria set forth in relevant laws and regulations, ensuring their eligibility for the incentive plan [2] Group 1 - The 2025 Stock Option Incentive Plan was reviewed and found to comply with the laws and regulations, promoting the company's sustainable development [2] - A total of 266 participants will be granted 12.27 million stock options, with the grant date set for September 4, 2025 [2]

Group 1 - The company held its 12th meeting of the 4th Supervisory Board on September 4, 2025, with all three supervisors present, complying with relevant laws and regulations [1][2] - The Supervisory Board approved the proposal to grant stock options to incentive targets, confirming that the granting date aligns with regulations and that conditions for granting have been met [1][2] - Legal opinions regarding the stock option incentive plan were provided and published on September 5, 2025, confirming the legality of the actions taken [1]

Core Points - The company has approved the cancellation of 5.05 million stock options due to the departure of 6 incentive targets and unmet performance goals for the first exercise period [1][2] - The cancellation of stock options will not affect the company's total share capital or share structure, ensuring no harm to the interests of all shareholders, especially minority shareholders [2] - Following the adjustments, the number of incentive targets for the 2024 stock option plan has been reduced from 176 to 170, and the number of stock options granted but not yet exercisable has been adjusted from 19.6 million to 14.55 million [2]

Core Viewpoint - The Sichuan Zigong Transportation Machinery Group Co., Ltd. has proposed a stock option incentive plan for 2025, aiming to enhance employee motivation and align their interests with the company's growth and shareholder value [1][2]. Summary by Sections Incentive Plan Overview - The plan involves granting a total of 4.98 million stock options, representing approximately 2.12% of the company's total share capital as of September 2, 2025 [2][12]. - The stock options will be granted in a one-time allocation without any reserved rights [2][12]. Stock Option Details - The exercise price for the stock options is set at 17.32 yuan per share [4][17]. - The plan will be effective for a maximum of 48 months from the date of stock option registration [3][6]. Eligible Participants - A total of 31 individuals, including directors, senior management, and middle management, will be eligible for the stock options, excluding independent directors and major shareholders [3][10]. - The plan aims to attract and retain talented personnel who directly impact the company's performance [19]. Vesting and Exercise Conditions - The stock options will vest in three phases: 40% after 12 months, 30% after 24 months, and 30% after 36 months from the grant date [3][14]. - The exercise of options is contingent upon meeting specific performance targets, including a net profit growth rate of at least 50% based on the previous year's net profit of 157 million yuan [21][22]. Adjustments and Compliance - The number of stock options and exercise price will be adjusted in case of corporate actions such as stock splits or capital increases [12][26]. - The plan requires approval from the company's shareholders and must comply with relevant laws and regulations [5][8]. Performance Assessment - The performance assessment will be conducted annually, with specific targets set for each year to determine the eligibility for exercising options [25][21]. - Individual performance will also be evaluated, impacting the actual number of options that can be exercised [23][25].

Group 1 - The core opinion of the article is that the Compensation and Assessment Committee of Guangdong Jushi Chemical Co., Ltd. has verified the list of incentive objects for the 2025 stock option incentive plan, confirming their eligibility under relevant laws and regulations [1][2]. - The committee has identified that the proposed incentive objects do not fall under any disqualifying conditions as outlined in the relevant legal frameworks, thus their qualifications are deemed legal and valid [2]. - The plan includes granting 1,200,000 stock options to 18 incentive objects, with an exercise price set at 14.95 yuan per option, with the reserved authorization date being September 3, 2025 [2]. Group 2 - The article outlines specific disqualifying conditions for incentive objects, including being recognized as inappropriate by the stock exchange or the China Securities Regulatory Commission (CSRC) within the last 12 months, or having been subject to administrative penalties or market entry bans due to major violations [1]. - The committee's verification process adheres to the provisions of the Company Law, Securities Law, and other relevant regulations, ensuring compliance with the guidelines for stock option incentives [1][2].

Core Viewpoint - The company has approved the 2025 Stock Option Incentive Plan and has conducted a verification of the list of incentive recipients, ensuring compliance with relevant regulations and internal standards [1][2][3] Summary by Sections Public Disclosure and Verification Process - The company publicly disclosed the list of incentive recipients for the 2025 Stock Option Incentive Plan on August 23, 2025, with a feedback period until September 1, 2025 [1] - During the public disclosure period, the Compensation and Assessment Committee received inquiries from employees regarding the criteria for the incentive recipients, which were addressed by the committee and relevant departments [2] Verification Committee's Findings - The Compensation and Assessment Committee verified the eligibility of the proposed incentive recipients, including their identification documents and employment contracts with the company and its subsidiaries [2] - The committee confirmed that all listed incentive recipients met the conditions set forth in the incentive plan and relevant regulations, with no objections raised during the public consultation [3]